Traitomic, a Copenhagen-based biotech company specializing in trait discovery for agriculture, has closed a €20 million Series A funding round to accelerate its commercial growth and establish itself as an independent business.
The round was led by Sofinnova Partners, with participation from EIFO, The Footprint Firm, PSV Hafnium, Nordic Foodtech VC, and SVG Ventures. The funding will enable the Danish company to pursue geographic expansion into the United States and Australia, broaden its service offering beyond trait discovery to include end-to-end development capabilities, and complete its transition from operating as a Carlsberg subsidiary.
Traitomic’s platform uses non-gene-edited approaches to identify and develop crop traits, positioning itself as an alternative to traditional genetic modification methods. The technology addresses growing market demand for solutions that can enhance crop performance while navigating varying regulatory landscapes across different regions.
Scaling Services and Market Reach
The company intends to leverage the capital to expand its scientific and commercial teams while establishing operational presence in key agricultural markets. By extending services from initial trait identification through to full development, Traitomic aims to become a more comprehensive partner for agricultural companies seeking innovation in crop improvement.
The timing of the round reflects increasing interest from major agricultural players in trait development technologies. Sara Sande, an investor in the round, noted that “we are already seeing demand from some of the world’s largest companies. It is that combination of strong technology, real industrial interest, and global potential that we are investing in.”
Independence and Growth
The Series A also marks an inflection point for Traitomic as it transitions toward full independence from its parent organization at Carlsberg. The Danish brewing giant had incubated the biotech spin-out, recognizing applications for trait development within its own operations. This funding round enables Traitomic to pursue a broader market opportunity across the entire agricultural sector.
The investment underscores the growing maturity of Denmark’s agritech ecosystem, which has attracted significant attention from both European and international venture investors. Copenhagen has emerged as a hub for agricultural innovation, with companies addressing challenges in crop productivity, sustainability, and food security positioning themselves at the intersection of traditional farming and biotechnology advancement.
Traitomic’s funding reflects broader trends within European agritech, where investors are increasingly backing companies developing alternative approaches to crop improvement that satisfy diverse regulatory requirements and market preferences. As global agricultural challenges intensify, trait development platforms that can operate across multiple regulatory frameworks are attracting substantial capital from both traditional agricultural investors and technology-focused venture firms.